The effect of disease modifying therapies on CD62L expression in multiple sclerosis.
Voortman MM, Greiner P, Moser D, Stradner MH, Graninger W, Moser A, Haditsch B, Enzinger C, Fuchs S, Fazekas F, Fessler J, Khalil M.
Voortman MM, et al. Among authors: greiner p.
Mult Scler J Exp Transl Clin. 2018 Sep 20;4(3):2055217318800810. doi: 10.1177/2055217318800810. eCollection 2018 Jul-Sep.
Mult Scler J Exp Transl Clin. 2018.
PMID: 30263146
Free PMC article.